Market Overview

Leerink Swann Downgrades MAP Pharmaceuticals, Inc. to Market Perform

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for MAPP

DateFirmActionFromTo
Mar 2013WedbushDowngradesOutperformNeutral
Feb 2013Ladenburg ThalmannDowngradesBuyNeutral
Jan 2013Deutsche BankDowngradesBuyHold

View More Analyst Ratings for MAPP
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (MAPP)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters